Overall, the five-year survival rate for oral cancer is 40-50%. Generally, the further anterior in the mouth the tumor occurs the better the prognosis. For example, over 90% of patients with cancer of the lower lip can expect a cure. For cancers involving the posterior tongue that are not associated with HPV16, the rate can be less than 30%. The presence of tumor in regional lymph nodes further reduces the overall 5-year survival rate by one-half. The continued use of tobacco after treatment for oral cancer increases the risk of recurrence. Patients with HPV16 associated carcinoma have a greatly improved 5-year survival rate showing excellent response to radiation and chemotherapy provided the patient has a less than 10 pack year history of tobacco use. In addition, all patients who have had cancer of the head and neck have a 5% risk per year of developing another tumor in the head and neck (second primary).
Your session is about to expire. Do you want to continue logged in?
WARNING! You did not finish creating your certificate. Please click CONTINUE below to return to your previous page to complete the process. Failure to complete ALL the steps will result in a loss of this test score, and you will not receive credit for this course.